Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Whitehouse Scientific CEO Presents New Work on Sieve Calibration at WCPT 7
Friday, May 16, 2014
Dr Graham Rideal will speak on ‘Calibrating test sieve apertures’ at the 7th WCPT 7 in Beijing, China.

Aptiv Solutions Improves Accuracy of Dose Escalation Studies with Launch of ADDPLAN® DF 3.0
Friday, May 16, 2014
ADDPLAN® DF 3.0 incorporates complex statistical methodologies to prevent under and over-estimation of a therapeutic’s maximum target dose (MTD) during Phase I dose escalation trials.

New Syringe Pump Enhanced for Glucose Clamp Studies
Saturday, May 10, 2014
New Pump 11 Elite Glucose Clamp Infusion System from Harvard.

Researchers from the Département Environnement et Agro-biotechnologies at the CRP
Saturday, May 10, 2014
Gabriel Lippmann in Luxembourg use Nanoparticle Tracking Analysis for toxicology studies.

Agilent Introduces Cary 8454 UV Dissolution System
Tuesday, May 06, 2014
Next-generation diode array UV dissolution system for the pharmaceutical industry.

Cotton Rat Influenza Model Launched by Noble Life Sciences
Wednesday, April 23, 2014
New cotton rat model for preclinical studies of influenza therapies and vaccines.

New XFe96 Spheroid Microplate from Seahorse Bioscience
Tuesday, April 22, 2014
The microplate enables functional, metabolic measurement of in vitro tumor spheroids.

ERT Introduces GE Healthcare’s QT Guard Plus™ Analysis System
Friday, April 11, 2014
Novel approach may help to prevent false positive cardiac safety findings in new drug development.

New Metrohm Brochure and Website Pharmaceutical Analysis
Tuesday, April 08, 2014
Metrohm’s new brochure Pharmaceutical analysis is a highly valuable compendium to get an overall view of the most important parameters determining the quality of pharmaceuticals and the methods best suited to check them.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 638
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv